Targeting Myotonic Dystrophy with Small Molecules

Show simple item record

dc.contributor.advisor Berglund, J en_US
dc.contributor.author Coonrod, Leslie en_US
dc.creator Coonrod, Leslie en_US
dc.date.accessioned 2012-10-26T03:59:23Z
dc.date.available 2013-10-25T10:00:06Z
dc.date.issued 2012
dc.identifier.uri http://hdl.handle.net/1794/12379
dc.description.abstract Myotonic dystrophy (DM) is one of the most common forms of muscular dystrophy, characterized by its hallmark symptom myotonia. DM is an autosomal dominant disease caused by a toxic gain of function RNA. The toxic RNA is produced from expanded non-coding CTG/CCTG repeats, and these CUG/CCUG repeats sequester a family of RNA binding proteins. The Muscleblind-like (MBNL) family of RNA binding proteins are sequestered to the expanded CUG/CCUG repeats. The MBNL proteins are regulators of alternative splicing, and their sequestration to the toxic RNA leads to mis-splicing events, which are believed to cause the symptoms observed in DM patients. A previously reported screen for small molecules used to identify compounds that could disrupt MBNL from binding the toxic CUG repeats found that pentamidine was able to rescue splicing defects associated with DM. Herein, we present a new class of molecules (phenolsulphonphthaleins) that inhibited MBNL1/CUG repeat complex formation in a competitive electrophoretic mobility shift assay (EMSA). Additionally, one of these molecules, bromophenol blue (BPB), acted in a synergistic manner with the previously described inhibitor pentamidine. We also demonstrated that the halogenation of the phenolsulphonphthalein dyes is an important factor for activity. Moreover, we presentant analysis of a series of methylene linker variants of pentamidine that revealed heptamidine (an analog of pentamidine) could reverse splicing defects in a DM1 tissue culture model and rescue myotonia in a DM1 mouse model. Finally, we report on a new crystal structure of CUG repeats, crystallized in the context of a GAAA tetraloop/receptor which facilitated ordered packing within the crystal. This structure was consistent with previous structures showing that the repeats are essentially A-form RNA, despite having a U-U mismatch every third base pair. We also identified six types of U-U mismatch in the context of the 5'CUG/3'GUC motif, suggesting that the interactions between the uridines are dynamic. This structure also contains the highest resolution GAAA tetraloop/receptor structure (1.95 Å) reported to date. This dissertation includes previously unpublished co-authored material. en_US
dc.language.iso en_US en_US
dc.publisher University of Oregon en_US
dc.rights All Rights Reserved. en_US
dc.subject CUG repeats en_US
dc.subject Myotonic Dystrophy en_US
dc.subject RNA structure en_US
dc.subject Small molecule en_US
dc.subject Toxic RNA en_US
dc.title Targeting Myotonic Dystrophy with Small Molecules en_US
dc.type Electronic Thesis or Dissertation en_US


Files in this item

Files Size Format View
Coonrod_oregon_0171A_10367.pdf 12.94Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record